DMC raises total of $39M with addition of new investors

In Colorado, DMC Biotechnologies, Inc. announced that strategic investors Continental Grain Company, through their venture arm Conti Ventures, and Toyobo have joined the Series B fundraising round, bringing the total raised to $39 million.

DMC previously announced the first close of its Series B fundraising on 2 December 2021 with investment from Cibus Enterprise, Capricorn Partners, Sofinnova Partners, Breakthrough Energy Ventures, SCG, Boulder Ventures, Solvay Ventures and Michelin.

DMC is commercial with its first product, a bio-based chemical intermediate with primary applications in sustainable detergents and human nutrition. DMC has a deep pipeline of predictable, scalable, and cost-competitive products that provide sustainable and economically attractive solutions for many industries, including animal nutrition, human nutrition, personal and home care, and biobased chemical intermediates.